Jennison Associates
LOXO

Jennison Associates’s Loxo Oncology, Inc LOXO Stock Holding History

Jennison Associates’s Portfolio LOXO Stock Details LOXO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		– Sell
-125,000
Closed -$1.64M – 780
2014
Q3 		$1.64M Buy
+125,000
New +$1.62M ﹤0.01% 605

Other funds holding LOXO

AC
Aisling Capital New York $45.3M AUM 15.24% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
RIM
RS Investment Management San Francisco, California $9.73B AUM 3.24% 1-Year Est. Return
VAM
Visium Asset Management New York $1.43B AUM 3.58% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
Axa
Axa Paris, France $91.9M AUM 27.41% 1-Year Est. Return

Jennison Associates's LOXO Position: Q4 2014 in Review

Jennison Associates sold out of Loxo Oncology, Inc (LOXO) in Q4 2014, closing a stake of 125,000 shares — an estimated $1.64M sold.

Jennison Associates first reported a position in LOXO in Q3 2014 and held it in 1 quarter. The position peaked at $1.64M in Q3 2014. 42 funds tracked by Wall St. Rank hold LOXO as of Q4 2014.

  • Jennison Associates reported no remaining Loxo Oncology, Inc position as of Q4 2014 after selling out during the quarter.
  • Jennison Associates sold 125,000 Loxo Oncology, Inc shares in Q4 2014, an estimated $1.64M.
  • Jennison Associates first reported a position in Loxo Oncology, Inc in Q3 2014 and held it in 1 quarter.
  • Jennison Associates's Loxo Oncology, Inc position peaked at $1.64M in Q3 2014.
  • 42 funds tracked by Wall St. Rank held Loxo Oncology, Inc as of Q4 2014.

Based on Jennison Associates's 13F filing for Q4 2014, filed 6 Feb 2015.